Information Provided By: 
Fly News Breaks for May 23, 2019
IDXX
May 23, 2019 | 07:24 EDT
Guggenheim analyst David Westenberg initiated coverage on 10 companies in animal health, starting Idexx Laboratories with a Buy rating and $276 price target. He believes share gains and utilization growth should continue for Idexx in the intermediate to long-term, making him "ok with a less than optimal 2019 stock set up," the analyst tells investors.
News For IDXX From the Last 2 Days
There are no results for your query IDXX
